Platelet microparticles reprogram macrophage gene expression and function

Summary

Platelet microparticles (MPs) represent the most abundant MPs subtype in the circulation, and can mediate intercellular communication through delivery of bioactives molecules, such as cytokines, proteins, lipids and RNAs. Here, we show that platelet MPs can be internalised by primary human macrophages and deliver functional miR-126–3p. The increase in macrophage miR-126–3p levels was not prevented by actinomycin D, suggesting that it was not due to de novo gene transcription. Platelet MPs dose-dependently downregulated expression of four predicted mRNA targets of miR-126–3p, two of which were confirmed also at the protein level. The mRNA downregulatory effects of platelet MPs were abrogated by expression of a neutralising miR-126–3p sponge, implying the involvement of miR-126–3p. Transcriptome-wide, microarray analyses revealed that as many as 66 microRNAs and 653 additional RNAs were significantly and differentially expressed in macrophages upon exposure to platelet MPs. More specifically, platelet MPs induced an upregulation of 34 microRNAs and a concomitant downregulation of 367 RNAs, including mRNAs encoding for cytokines/chemokines CCL4, CSF1 and TNF. These changes were associated with reduced CCL4, CSF1 and TNF cytokine/chemokine release by macrophages, and accompanied by a marked increase in their phagocytic capacity. These findings demonstrate that platelet MPs can modify the transcriptome of macrophages, and reprogram their function towards a phagocytic phenotype.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Platelet - microparticle - macrophage - microRNA - gene regulation

^# The first two authors contributed equally to this work and should be considered as co-first authors.

• References

• 1 Michelson AD. How platelets work: platelet function and dysfunction. J Thromb Thrombol 2003; 16: 7-12.
• 2 Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009; 19: 43-51.
• 3 Berckmans RJ, Nieuwland R, Boing AN. et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-646.
• 4 Arraud N, Linares R, Tan S. et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost 2014; 12: 614-627.
• 5 Boilard E, Nigrovic PA, Larabee K. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-583.
• 6 Owens 3rd AP, Mackman N. Microparticles in haemostasis and thrombosis. Circ Res 2011; 108: 1284-1297.
• 7 Rautou PE, Leroyer AS, Ramkhelawon B. et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res 2011; 108: 335-343.
• 8 Abdel-Monem H, Dasgupta SK, Le A. et al. Phagocytosis of platelet microve-sicles and beta2- glycoprotein I. Thromb Haemost 2010; 104: 335-341.
• 9 Dasgupta SK, Abdel-Monem H, Niravath P. et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009; 113: 1332-1339.
• 10 Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis 2006; 36: 182-187.
• 11 Loyer X, Vion AC, Tedgui A. et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014; 114: 345-353.
• 12 Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-1057.
• 13 Aatonen M, Gronholm M, Siljander PR. Platelet-derived microvesicles: multita-lented participants in intercellular communication. Semin Thromb Haemost 2012; 38: 102-113.
• 14 Sadallah S, Amicarella F, Eken C. et al. Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells. Thromb Haemost 2014; 112: 1219-1229.
• 15 Vasina EM, Cauwenberghs S, Feijge MA. et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011; 02: e211.
• 16 Bray PF, McKenzie SE, Edelstein LC. et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 2013; 14: 1.
• 17 Rowley JW, Oler AJ, Tolley ND. et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118: e101-111.
• 18 Schubert S, Weyrich AS, Rowley JW. A tour through the transcriptional landscape of platelets. Blood 2014; 124: 493-502.
• 19 Warshaw AL, Laster L, Shulman NR. Protein synthesis by human platelets. J Biol Chem 1967; 242: 2094-2097.
• 20 Landry P, Plante I, Ouellet DL. et al. Existence of a microRNA pathway in an-ucleate platelets. Nat Struct Mol Biol 2009; 16: 961-966.
• 21 Ple H, Landry P, Benham A. et al. The repertoire and features of human platelet microRNAs. PLoS One 2012; 07: e50746.
• 22 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
• 23 Laffont B, Corduan A, Ple H. et al. Activated platelets can deliver mRNA regulatory Ago2»microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.
• 24 Gidlof O, van der Brug M, Ohman J. et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 2013; 121: 3908-3917 S1-26.
• 25 Duchez AC, Boudreau LH, Bollinger J. et al. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci USA 2015; 112: E3564-3573.
• 26 Schrijvers DM, De Meyer GR, Herman AG. et al. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res 2007; 73: 470-480.
• 27 Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res 2013; 100: 7-18.
• 28 Rousseau M, Belleannee C, Duchez AC. et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One 2015; 10: e0116812.
• 29 Gobeil LA, Lodge R, Tremblay MJ. Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with cell activation status. J Virol 2012; 86: 10399-10407.
• 30 Pepin G, Perron MP, Provost P. Regulation of human Dicer by the resident ER membrane protein CLIMP-63. Nucleic Acids Res 2012; 40: 11603-11617.
• 31 Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microR-NAs can up-regulate translation. Science 2007; 318: 1931-1934.
• 32 Rees AJ. Monocyte and macrophage biology: an overview. Semin Nephrol 2010; 30: 216-233.
• 33 Zampetaki A, Willeit P, Tilling L. et al. Prospective study on circulating MicroR-NAs and risk of myocardial infarction. J Am Coll Cardiol 2012; 60: 290-299.
• 34 Verschoor CP, Puchta A, Bowdish DM. The macrophage. Methods Mol Biol 2012; 844: 139-156.
• 35 Lasbury ME, Tang X, Durant PJ. et al. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infection Immunity 2003; 71: 4943-4952.
• 36 Seyrantepe V, Iannello A, Liang F. et al. Regulation of phagocytosis in macro-phages by neuraminidase 1. J Biol Chem 2010; 285: 206-215.
• 37 Ray DM, Spinelli SL, Pollock SJ. et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 2008; 99: 86-95.
• 38 Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-126.
• 39 Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-225.
• 40 Irvine KM, Andrews MR, Fernandez-Rojo MA. et al. Colony-stimulating fac-tor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukoc Biol 2009; 85: 278-288.
• 41 Branen L, Hovgaard L, Nitulescu M. et al. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004; 24: 2137-2142.
• 42 Ohta H, Wada H, Niwa T. et al. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005; 180: 11-17.
• 43 Zernecke A, Bidzhekov K, Noels H. et al. Delivery of microRNA-126 by apop-totic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 02: ra81.
• 44 Bijkerk R, van Solingen C, de Boer HC. et al. Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. J Am Soc Nephrol 2014; 25: 1710-1722.
• 45 Schober A, Nazari-Jahantigh M, Wei Y. et al. MicroRNA-126-5p promotes en-dothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014; 20: 368-376.
• 46 Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 05: 953-964.
• 47 Sadallah S, Eken C, Martin PJ. et al. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011; 186: 6543-6552.
• 48 Stuart LM, Ezekowitz RA. Phagocytosis: elegant complexity. Immunity 2005; 22: 539-550.
• 49 Michlewska S, Dransfield I, Megson IL. et al. Macrophage phagocytosis of apop-totic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J 2009; 23: 844-854.
• 50 Feng X, Deng T, Zhang Y. et al. Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor alpha and growth arrest-specific gene 6. Immunology 2011; 132: 287-295.
• 51 Rayner KJ, Sheedy FJ, Esau CC. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011; 121: 2921-2931.
• 52 Schaefer A, Jung M, Miller K. et al. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 2010; 42: 749-758.